Personalized psychiatry: a realistic goal

被引:23
作者
Gurwitz, D [1 ]
Weizman, A
机构
[1] Tel Aviv Univ, Sackler Fac Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel
关键词
antidepressant drugs; antipsychotic drugs; brain-derived neurotrophic factor; depression; gene; polymorphism; personalized; psychiatry; schizophrenia; SSRIs;
D O I
10.1517/phgs.5.2.213.27487
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is becoming increasingly evident that the implementation of true personalized medicine will not come as rapidly and smoothly as initially hoped. In the aftermath of the drafting of the human genome in 2001, the popular and scientific media featured numerous commentaries heralding the approaching arrival of personalized medicine to the clinic, and describing its huge benefits for patients. Media coverage predicted a drastic transformation for the practice of medicine, second to the revolution brought about by the discovery of vaccines and antibiotics. From the perspective of another 3 years, during which substantial new insights were made into the enormous complexity of human genome variation, it seems that true personalized medicine may still be decades away for many aspects of medical treatment. Nonetheless, the prospects for implementation of at least certain elements of personalized medicine for one key discipline, psychiatry, might be relatively close and more realistic. With the correct focus, realization of some benefits of genetic patient profiling for psychiatric pharmacotherapy might be near, and in due course, lead the way for true personalized psychiatry.
引用
收藏
页码:213 / 217
页数:5
相关论文
共 38 条
  • [1] With your genes? Take one of these, three times a day
    Abbott, A
    [J]. NATURE, 2003, 425 (6960) : 760 - 762
  • [2] BRAIN-DERIVED NEUROTROPHIC FACTOR AUGMENTS ROTATIONAL BEHAVIOR AND NIGROSTRIATAL DOPAMINE TURNOVER INVIVO
    ALTAR, CA
    BOYLAN, CB
    JACKSON, C
    HERSHENSON, S
    MILLER, J
    WIEGAND, SJ
    LINDSAY, RM
    HYMAN, C
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) : 11347 - 11351
  • [3] Neurotrophic factors and CNS disorders:: findings in rodent models of depression and schizophrenia
    Angelucci, F
    Mathé, AA
    Aloe, L
    [J]. NGF AND RELATED MOLECULES IN HEALTH AND DISEASE, 2004, 146 : 151 - 165
  • [4] [Anonymous], 2003, INDEPENDENT 1208
  • [5] BRADFORD LD, 2004, UNPUB PHARMACOGENOMI
  • [6] Pharmacogenetics: Ethical issues and policy options
    Buchanan, A
    Califano, A
    Kahn, J
    McPherson, E
    Robertson, J
    Brody, B
    [J]. KENNEDY INSTITUTE OF ETHICS JOURNAL, 2002, 12 (01) : 1 - 15
  • [7] Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2
    Chen, WG
    Chang, Q
    Lin, YX
    Meissner, A
    West, AE
    Griffith, EC
    Jaenisch, R
    Greenberg, ME
    [J]. SCIENCE, 2003, 302 (5646) : 885 - 889
  • [8] Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia
    Chumakov, I
    Blumenfeld, M
    Guerassimenko, O
    Cavarec, L
    Palicio, M
    Abderrahim, H
    Bougueleret, L
    Barry, C
    Tanaka, H
    La Rosa, P
    Puech, A
    Tahri, N
    Cohen-Akenine, A
    Delabrosse, S
    Lissarrague, S
    Picard, FP
    Maurice, K
    Essioux, L
    Millasseau, P
    Grel, P
    Debailleul, V
    Simon, AM
    Caterina, D
    Dufaure, I
    Malekzadeh, K
    Belova, M
    Luan, JJ
    Bouillot, M
    Sambucy, JL
    Primas, G
    Saumier, M
    Boubkiri, N
    Martin-Saumier, S
    Nasroune, M
    Peixoto, H
    Delaye, A
    Pinchot, V
    Bastucci, M
    Guillou, S
    Chevillon, M
    Sainz-Fuertes, R
    Meguenni, S
    Aurich-Costa, J
    Cherif, D
    Gimalac, A
    Van Duijn, C
    Gauvreau, D
    Quelette, G
    Fortier, I
    Realson, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) : 13675 - 13680
  • [9] A vision for the future of genomics research
    Collins, FS
    Green, ED
    Guttmacher, AE
    Guyer, MS
    [J]. NATURE, 2003, 422 (6934) : 835 - 847
  • [10] Personalized medicine: revolutionizing drug discovery and patient care
    Ginsburg, GS
    McCarthy, JJ
    [J]. TRENDS IN BIOTECHNOLOGY, 2001, 19 (12) : 491 - 496